Patent Licence Agreement (Singapore)

A Patent Licence Agreement in Singapore grants defined rights to use the licensed subject matter on the terms it specifies.

Singapore's patent licensing framework operates within the intersection of intellectual property law, contract law, and competition law. The Intellectual Property Office of Singapore (IPOS) maintains the Register of Patents, and Section 43(4) of the Patents Act provides that a patent licence may be registered with IPOS — registration is not mandatory but provides important benefits, including priority over subsequently registered interests and protection against a bona fide purchaser of the patent who does not have notice of the licence.

The Competition Act (Cap. 50B), administered by the Competition and Consumer Commission of Singapore (CCCS), imposes constraints on patent licensing terms that may restrict competition. Section 34 of the Competition Act prohibits agreements that have as their object or effect the prevention, restriction, or distortion of competition within Singapore. Certain licensing practices — such as exclusive grant-back clauses, tying arrangements requiring the licensee to purchase unrelated products, and territorial restrictions that partition the market — may infringe Section 34 if they substantially lessen competition. The CCCS has published Guidelines on the Treatment of Intellectual Property Rights that provide a safe harbour for IP licensing agreements where the combined market share of the licensor and licensee does not exceed 25%.

Patent licence agreements in Singapore may take several forms: an exclusive licence (the licensee is the only party authorised to exploit the patent, to the exclusion of all others including the licensor); a sole licence (the licensor retains the right to exploit the patent but grants the licence to one licensee only); or a non-exclusive licence (the licensor may grant licences to multiple licensees and retain its own right to exploit). The type of licence significantly affects the licensee's enforcement rights — under Section 67 of the Patents Act, an exclusive licensee has the same right as the patent owner to bring infringement proceedings, while a non-exclusive licensee does not have standing to sue for infringement unless the licence agreement confers this right.

Royalty payments under patent licences in Singapore are subject to withholding tax under Section 12(7) of the Income Tax Act (Cap. 134) when paid to a non-resident licensor. The standard withholding tax rate on royalties is 10%, subject to any applicable Avoidance of Double Taxation Agreement (DTA) between Singapore and the licensor's country of tax residence. The Inland Revenue Authority of Singapore (IRAS) administers withholding tax obligations, and the licensee must withhold and remit the tax to IRAS within 15 days of payment. A related Copyright Licence Agreement or Trademark Licence Agreement may be needed where the licensed technology includes copyrighted software or branded products.

A Patent Licence Agreement is needed whenever the owner of a Singapore patent wishes to allow another party to exploit the patented invention commercially without transferring ownership of the patent itself.

Technology companies and manufacturers that have developed patented products or processes but lack the manufacturing capacity, distribution network, or market presence in Singapore or a target territory need a Patent Licence Agreement to authorise a licensee to manufacture and sell the patented product. Section 43 of the Patents Act (Cap. 221) provides the statutory basis for patent licensing, and a written licence agreement protects both parties' interests by defining the scope, territory, duration, and financial terms of the licence.

Research institutions and universities — including the National University of Singapore (NUS), Nanyang Technological University (NTU), the Agency for Science, Technology and Research (A*STAR), and the Singapore University of Technology and Design (SUTD) — that have obtained patents for research outputs need Patent Licence Agreements to commercialise their inventions through industry partners. Technology transfer offices at these institutions routinely negotiate patent licences with local and multinational companies, and the licence terms must comply with the institution's technology transfer policies and any funding conditions imposed by the National Research Foundation (NRF) or Enterprise Singapore (EnterpriseSG).

Foreign patent owners seeking to enter the Singapore market by licensing their patents to local companies need a Patent Licence Agreement that addresses Singapore-specific requirements — including registration with IPOS under Section 43(4) of the Patents Act, withholding tax obligations on royalty payments under the Income Tax Act (Cap. 134), competition law compliance under the Competition Act (Cap. 50B), and dispute resolution through the Singapore International Arbitration Centre (SIAC) or the Singapore courts.

Companies engaged in cross-licensing arrangements — where two or more patent owners grant each other licences to their respective patent portfolios — need Patent Licence Agreements that clearly define the scope of each licence, the treatment of improvements and future patents, and the dispute resolution mechanism. Cross-licensing is common in the technology, telecommunications, and pharmaceutical sectors in Singapore.

Companies at risk of patent infringement proceedings may need a Patent Licence Agreement to settle the dispute — the patent owner agrees to grant a licence in exchange for royalty payments, and the alleged infringer obtains the right to continue manufacturing or selling the product. Settlement through licensing is encouraged by the Singapore courts and IPOS as a cost-effective alternative to contested infringement proceedings. A related IP Assignment Agreement transfers outright ownership rather than granting a licence.

A Singapore Patent Licence Agreement compliant with the Patents Act (Cap. 221), the Competition Act (Cap. 50B), and IRAS withholding tax requirements must include the following elements. The forms-legal.com Patent Licence Agreement template covers all essential provisions for Singapore patent licensing, structured to address both domestic and cross-border licensing arrangements.

Party identification requires the licensor's full name or company name and UEN registered with ACRA (or the foreign company's registration details and registered address), and the licensee's full name or company name and UEN. Where the licensor is a joint patent owner, all co-owners must be parties to the licence agreement unless one co-owner has been authorised to grant licences on behalf of all co-owners.

Patent identification must specify the Singapore patent number, the title of the invention, the filing date, the grant date, and the expiry date. If the licence covers patent applications that have not yet been granted, the patent application number should be stated with a provision addressing the consequences of the application being refused or amended during examination. Where the licence covers a portfolio of patents, each patent should be listed in a schedule with its registration details.

Licence scope and type must clearly define: (1) the type of licence — exclusive, sole, or non-exclusive — and the corresponding enforcement rights; (2) the licensed acts — whether the licensee may make, use, sell, offer to sell, import, or sublicense the patented invention; (3) the territorial scope — whether the licence is limited to Singapore or extends to other jurisdictions; and (4) any field-of-use restrictions (e.g., the licensee may exploit the patent for medical devices but not consumer electronics). The CCCS Guidelines on the Treatment of Intellectual Property Rights should be consulted to avoid restrictions that infringe Section 34 of the Competition Act.

Royalty and payment terms must specify the financial consideration — typically structured as: an upfront lump-sum payment; ongoing royalties calculated as a percentage of net sales or net revenue; minimum annual royalty payments (a guaranteed minimum regardless of actual sales); and milestone payments tied to specific commercial achievements (e.g., first commercial sale, regulatory approval, or cumulative sales thresholds). The agreement should specify the currency (SGD or the licensor's preferred currency), the payment frequency (quarterly or semi-annually), and the reporting and audit obligations.

Withholding tax provisions are critical for cross-border licences. Under Section 12(7) of the Income Tax Act (Cap. 134), royalty payments to a non-resident licensor are subject to withholding tax at 10% (or the reduced rate under an applicable DTA). The agreement should specify which party bears the economic cost of the withholding tax — typically the licensor receives royalties net of withholding tax, with the licensee remitting the withheld amount to IRAS within 15 days.

Improvement and grant-back provisions should address whether improvements to the patented invention made by the licensee must be disclosed and/or licensed back to the licensor, and on what terms. An exclusive grant-back obligation — requiring the licensee to assign all improvements to the licensor — may raise competition law concerns under Section 34 of the Competition Act and should be reviewed against the CCCS Guidelines.

Term and termination must specify the licence duration (typically aligned with the remaining patent term, which is 20 years from the filing date under the Patents Act), renewal provisions, and grounds for termination — including non-payment of royalties, material breach, insolvency, and the licensee challenging the validity of the patent. A related Non-Disclosure Agreement should be executed alongside the licence to protect confidential technical information disclosed during the licensing relationship.